Beta-arrestin 2 is required for dopamine receptor type 2 inhibitory effects on AKT phosphorylation and cell proliferation in pituitary tumors

Federica Mangili, Elena Giardino, Donatella Treppiedi, Anna Maria Barbieri, Rosa Catalano, Marco Locatelli, Andrea Gerardo Lania, Anna Spada, Maura Arosio, Giovanna Mantovani, Erika Peverelli

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Beta-arrestin 2 is required for dopamine receptor type 2 inhibitory effects on AKT phosphorylation and cell proliferation in pituitary tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences